Citibank

Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform

by | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
MORE